Methods for treating COVID-19
US11654132B2 · kind B2 · utility
0Cited by
7References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 29, 2022 |
| Grant date | May 23, 2023 |
| Priority date | — |
| Expiry date | Jun 29, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/06052
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to methods for treating COVID-19 by targeting the inflammasome/caspase1/pyroptosis axis as a key inflammatory pathway. In particular, the invention relates to treating a patient infected with SARS-CoV-2 with an effective amount of one or more compounds that directly or indirectly inhibit one or more pathways of the inflammasome/caspase1/pyroptosis axis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.